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We present a patient diagnosed with skin sarcoidosis, breast cancer, pulmonary tuberculosis, and peritoneal sarcoidosis 
with a past history of colorectal cancer. During stage work up for breast cancer, suspicious lesions on peritoneum were 
observed in imaging studies. Considering our patient’s history and imaging findings, we initially suspected peritoneal car-
cinomatosis. However, the peritoneal lesion was diagnosed as sarcoidosis in laparoscopic biopsy. This case demonstrates 
that abdominal sarcoidosis might be considered as a differential diagnosis when there is a lesion suspected of being peri-
toneal carcinomatosis with nontypical clinical presentations. 
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INTRODUCTION
Sarcoidosis is a systemic inflammatory disease in which noncase-
ating granulomas are characteristic pathologic findings. The etiol-
ogy of sarcoidosis is not yet well understood. Both clinical and 
pathologic features should be considered in the diagnosis of sar-
coidosis. Other granulomatous diseases should be excluded be-
fore diagnosis. Sarcoidosis is well knowing most commonly to af-
fect the lungs, with more than 90% of sarcoidosis patients show-
ing lung involvement. However, any organ can be involved [1]. 
Because peritoneal sarcoidosis is extremely rare, it is often misdi-
agnosed in clinical practice [2].
When abnormal nodules or a fluorodeoxyglucose (FDG) uptake 
is observed in imaging studies on patients with a history of can-
cer, a strong tendency exists to suspect peritoneal carcinomatosis. 
Although peritoneal sarcoidosis is a very rare disease, proper dis-
crimination between carcinomatosis and sarcoidosis is important 
because the therapeutic approach may be completely different. 
However, a differential diagnosis by using imaging is difficult be-
cause both diseases appear similar in computed tomography (CT) 
and may show FDG uptake in 18F-FDG positron emission tomog-
raphy (PET)/CT [3, 4]. 
Here, we describe a rare case in which abnormal FDG uptakes 
seen in lungs and peritoneal walls in a PET-CT scan intended for 
cancer staging were assumed to be metastatic disease. However, 
they were later found to be tuberculosis and sarcoidosis, respec-
tively.
CASE REPORT
A 70-year-old female who underwent a laparoscopic right hemi-
colectomy was diagnosed in June 2013 as having early colon can-
cer (T1N0M0). She visited a local clinic in June 2015 due to mul-
tiple skin-colored nodules and a palpable mass in the left breast. 
Biopsy revealed that the skin lesion was sarcoidosis and the breast 
mass was breast cancer. The patient was referred to our hospital. 
She underwent chest CT, abdominopelvic CT, and 18F-FDG PET/
CT. The chest CT showed possible metastatic lymph nodes in the 
left lower neck, mediastinum, and bilateral hilar/right interlobar 
lymph-node-bearing area, and a few round small nodules in the 
right upper lobe, which could have been metastatic nodules. Ab-
dominopelvic CT revealed newly developed omental infiltration/
nodules with small pelvic ascites and infiltrative thickening/en-
hancement of the left rectus muscle suggestive of peritoneal seed-
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ing or abdominal wall metastasis. In 18F-FDG PET/CT, increased 
FDG uptakes in the left subareolar area, left axillary lymph node, 
right upper lobe of the lung, bilateral hilar and mediastinal lymph 
nodes, omentum, and uterus, as well as peritoneal thickening in 
the pelvic cavity along the left anterior abdominal wall, were 
noted (Fig. 1). All these findings were suspected to be multiple 
metastases from the previously resected colon cancer or newly 
developed breast cancer. However, sarcoidosis was also consid-
ered because of her history of skin sarcoidosis with bilateral hilar 
and mediastinal lymphadenopathy. Therefore, pathologic confir-
mation was planned to distinguish cancer metastasis from other 
systematic inflammatory diseases. 
A wedge resection of the right upper lobe of the lung and a bi-
opsy of the mediastinal lymph node were performed initially. 
Pathologic results confirmed that those findings for the lung were 
not due to metastatic lesions. We decided to perform a modified 
radical mastectomy of the left breast. Because the abdominopelvic 
CT and the PET-CT imaging studies had suggested possible peri-
toneal carcinomatosis, we decided to perform a diagnostic lapa-
roscopy of the abdomen simultaneously with the mastectomy. 
One week later, the patient underwent a total mastectomy of the 
left breast with axillary lymph node dissection. A diagnostic lapa-
roscopic peritoneal biopsy was simultaneously performed to 
identify the origin of the lesion that was suspected to be perito-
neal carcinomatosis. Innumerable small-sized nodular lesions 
were seen in the peritoneal cavity. Part of the omentum and a 
nodular lesion of the left pelvic wall were resected for pathologic 
confirmation (Fig. 2).
Pathology reports revealed that the breast lesion was an invasive 
ductal carcinoma with axillary lymph node metastasis while the 
lung mass was chronic granulomatous inflammation with necro-
sis, consistent with tuberculosis in the right upper lobe of the 
lung. In this specimen, a few acid-fast bacilli were identified on 
Ziehl-Neelsen staining. Resected lymph nodes near the lung 
showed nonnecrotizing granulomas suspicious of sarcoidosis. Bi-
opsy for a sample of the peritoneal wall and resected omentum 
revealed nonnecrotizing granulomas, which favored a diagnosis 
of sarcoidosis. No acid-fast bacilli were identified on Ziehl-
Neelsen staining of the abdominal biopsy samples (Fig. 3). 
The patient received isoniazid, rifampin, and ethambutol for 
nine months for tuberculosis. She received 4 cycles of adjuvant 
TC (docetaxel + cyclophosphamide) chemotherapy, PMRT (post 
mastectomy radiotherapy, 5,040 cGy), and 18 cycles of adjuvant 
Herceptin. Currently, this patient is taking letrozole. Most cases of 
peritoneal sarcoidosis are known usually to have a benign course 
[5]. Therefore, we planned to observe her progress without treat-
ment for peritoneal sarcoidosis. After the breast cancer surgery 
and the abdominal diagnostic laparoscopy, her case was followed, 
and to date, no other abnormal findings have been found.
Fig. 1. Positron emission tomography-computed tomography findings. Abnormal fluorodeoxyglucose uptake was observed in the mediasti-
num, left breast, left axilla and abdominal wall (A), bilateral hilum and mediastinal lymph node (arrow) (B), right upper lung field (arrow) (C), 
left breast (arrow) (D), and left axilla (arrow) (E).
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Fig. 3. Pathologic findings. (A) Scan power view showing a necrotic nodule abutting the pleura (H&E, ×12.5). (B) The nodule is composed of 
chronic granulomatous inflammation with caseating necrosis (H&E, ×100). (C) Ziehl-Neelsen staining reveals a few acid-fast bacilli (×1,000). 
(D) Small noncaseating granulomas are seen in hilar lymph nodes (H&E, ×200). (E) An invasive ductal carcinoma of the left breast (H&E, 
×400). (F) Omentum biopsy shows multiple tight clusters of small noncaseating granulomas (H&E, ×200).  
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Fig. 2. Positron emission tomography-computed tomography findings and laparoscopic view of the abdomen. Abnormal fluorodeoxyglucose 
uptake in the left anterior abdominal wall (white arrow) and left pelvic wall (black arrow) (A), and uterus (white arrow) (B). An abdominal in-
spection using a laparoscopic camera revealed numerous small nodular lesions in the left pelvic wall (C) and rectum and uterus (D).
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DISCUSSION
Peritoneal sarcoidosis is a very rare disease. It has a relatively in-
creased incidence in women aged between 20 and 40 years and is 
found in patients with an average age of 39.1 years. Symptoms as-
sociated with peritoneal sarcoidosis include abdominal pain and 
ascites. Laboratory examinations can show an increased level of 
angiotensin converting enzyme (ACE) [6]. However, the sensitiv-
ity of high ACE levels for the diagnosis of sarcoidosis is low 
(41.4%), and its specificity is insufficient (89.9%). Therefore, ACE 
level has a limited role for diagnostic purposes [7]. In our case, the 
patient did not complain of any abdominal symptoms, and her 
ACE level was within normal range during the treatment process. 
Thus, neither the laboratory findings nor the clinical symptoms 
provided any clue that could aid us to suspect peritoneal sarcoid-
osis. 
This was a rare case in which the patient was simultaneously di-
agnosed with left breast cancer, pulmonary tuberculosis, and in-
trathoracic and extrathoracic sarcoidosis involvement, especially 
in the skin, hilar lymph nodes, and abdominal peritoneum. Be-
cause the patient had a history of a radical resection of ascending 
colon cancer, the observed increased FDG uptakes in the omen-
tum and the uterus, as well as the peritoneal thickening in the pel-
vic cavity, were initially highly suspected as being caused by peri-
toneal metastasis from colon cancer or newly developed breast 
cancer. The patient did not receive adjuvant chemotherapy after 
the colon cancer resection because she was in pathologic stage I. 
The prognosis of stage I colorectal cancer with adequate surgery 
is reported to be good, with a 5-year survival rate of over 90% [8]. 
However, the possibility of colon cancer that had metastasized to 
the peritoneum could not be excluded because several cases have 
been reported where peritoneal metastases was later found in pa-
tients who had initially been diagnosed with stage I colorectal 
cancer [9]. Peritoneal carcinomatosis occurs in 8% of colorectal 
cancer patients. The incidence of breast cancer metastasis to the 
peritoneum is as low as 0.7%. Although cytoreductive surgery 
with hyperthermic intraperitoneal chemotherapy (CRS with 
HIPEC) has been regarded as an effective treatment in patients 
with peritoneal carcinomatosis originating from colorectal cancer, 
the grades III–IV morbidity rate after CRS with HIPEC ranges 
from 22%–34%, and mortality rate ranges from 0.8%–4.1% [10]. 
Therefore, confirmation of the pathologic diagnosis is very im-
portant before conducting such serious operations. In one report, 
a patient underwent a total abdominal hysterectomy, bilateral sal-
pingo-oophorectomy, total omentectomy, and appendectomy due 
to suspected ovarian cancer with peritoneal metastases. However, 
the final report showed that those nodules were abdominal sar-
coidosis [2]. Therefore, an accurate diagnosis should be made to 
avoid unnecessary treatment in sarcoidosis.
For our patient, peritoneal carcinomatosis was initially sus-
pected due to the CT findings. However, the CT findings for peri-
toneal carcinomatosis are nonspecific, and nodules smaller than 1 
cm might be invisible in the images [11]. 18F-FDG PET/CT might 
be able to compensate for this limitation. Several studies have re-
vealed that compared to other image modalities, PET/CT scans 
show high sensitivity and positive predictive value for detecting 
peritoneal carcinomatosis. According to a meta-analysis, 18F-FDG 
PET or PET/CT has a good positive likelihood ratio and a high 
specificity, suggesting that 18F-FDG PET or PET/CT is reliable for 
detecting peritoneal carcinomatosis when abnormal uptake is ob-
served [12, 13]. In our case, a 18F-FDG PET/CT scan suggested 
the possibility of peritoneal dissemination from malignancies. 
However, final pathologic results demonstrated that making an 
accurate diagnosis of peritoneal metastasis by using 18F-FDG 
PET/CT is difficult. 
For cases of peritoneal carcinomatosis, the treatment strategy 
might depend on the origin of the primary cancer. In this regard, 
laparoscopic tissue confirmation is necessary. On laparoscopy, 
small nodular lesions were observed in the left pelvic wall and 
uterus in our case. However, discriminating peritoneal carcino-
matosis from other origins by using only visual examination was 
very difficult. Before pathologic tissue confirmation, we were un-
sure whether the condition was peritoneal sarcoidosis or perito-
neal carcinomatosis. Thus, this case demonstrated that peritoneal 
sarcoidosis could be misdiagnosed as peritoneal carcinomatosis 
after imaging studies, including PET/CT studies and gross find-
ings. 
In our case, although the 18F-FDG PET/CT scan suggested the 
possibility of peritoneal dissemination from malignancies, the 
possible cause of the peritoneal spread was uncertain based on the 
initial clinical presentations. This case demonstrates that abdomi-
nal sarcoidosis might be considered as a differential diagnosis 
when a lesion is suspected of being peritoneal carcinomatosis 
upon abnormal clinical presentation. 
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